Exagen Inc Stock Price History
| XGN Stock | USD 3.99 0.93 30.39% |
Below is the normalized historical share price chart for Exagen Inc extending back to September 19, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Exagen stands at 3.99, as last reported on the 19th of January, with the highest price reaching 4.09 and the lowest price hitting 3.04 during the day.
If you're considering investing in Exagen Stock, it is important to understand the factors that can impact its price. Exagen appears to be very risky, given 3 months investment horizon. Exagen Inc secures Sharpe Ratio (or Efficiency) of 0.11, which denotes the company had a 0.11% return per unit of standard deviation over the last 3 months. By reviewing Exagen's technical indicators, you can evaluate if the expected return of 0.9% is justified by implied risk. Please utilize Exagen's Downside Deviation of 6.37, mean deviation of 5.68, and Semi Deviation of 5.78 to check if our risk estimates are consistent with your expectations.
At this time, Exagen's Common Stock Shares Outstanding is very stable compared to the past year. As of the 19th of January 2025, Other Stockholder Equity is likely to grow to about 364.5 M, while Total Stockholder Equity is likely to drop about 20.5 M. . As of the 19th of January 2025, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price To Sales Ratio is likely to drop 0.57. Exagen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of September 2019 | 200 Day MA 2.6679 | 50 Day MA 3.9367 | Beta 1.346 |
Exagen |
Sharpe Ratio = 0.1083
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | XGN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.35 actual daily | 74 74% of assets are less volatile |
Expected Return
| 0.9 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Exagen is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Exagen by adding it to a well-diversified portfolio.
Price Book 4.1941 | Enterprise Value Ebitda (0.16) | Price Sales 1.242 | Shares Float 6.8 M | Wall Street Target Price 6.75 |
Exagen Stock Price History Chart
There are several ways to analyze Exagen Stock price data. The simplest method is using a basic Exagen candlestick price chart, which shows Exagen price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 16, 2024 | 6.0 |
| Lowest Price | October 31, 2024 | 2.43 |
Exagen January 19, 2025 Stock Price Synopsis
Various analyses of Exagen's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Exagen Stock. It can be used to describe the percentage change in the price of Exagen from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Exagen Stock.| Exagen Price Rate Of Daily Change | 1.30 | |
| Exagen Price Action Indicator | 0.89 | |
| Exagen Price Daily Balance Of Power | 0.89 |
Exagen January 19, 2025 Stock Price Analysis
Exagen Stock Price History Data
The price series of Exagen for the period between Mon, Oct 21, 2024 and Sun, Jan 19, 2025 has a statistical range of 3.57 with a coefficient of variation of 27.61. The daily prices for the period are distributed with arithmetic mean of 3.66. The median price for the last 90 days is 3.29.| Open | High | Low | Close | Volume | ||
01/19/2025 | 3.08 | 4.09 | 3.04 | 3.99 | ||
| 01/17/2025 | 3.08 | 4.09 | 3.04 | 3.99 | 810,987 | |
| 01/16/2025 | 3.12 | 3.12 | 3.00 | 3.06 | 58,236 | |
| 01/15/2025 | 3.03 | 3.16 | 2.76 | 3.12 | 94,167 | |
| 01/14/2025 | 3.12 | 3.18 | 2.92 | 3.00 | 240,144 | |
| 01/13/2025 | 3.17 | 3.30 | 3.02 | 3.12 | 79,443 | |
| 01/10/2025 | 3.27 | 3.27 | 3.05 | 3.17 | 53,296 | |
| 01/08/2025 | 3.20 | 3.40 | 3.20 | 3.29 | 80,710 | |
| 01/07/2025 | 3.26 | 3.39 | 3.20 | 3.27 | 122,749 | |
| 01/06/2025 | 3.55 | 3.73 | 3.32 | 3.39 | 171,289 | |
| 01/03/2025 | 3.05 | 3.98 | 3.00 | 3.58 | 481,958 | |
| 01/02/2025 | 4.07 | 4.28 | 3.00 | 3.09 | 719,566 | |
| 12/31/2024 | 4.22 | 4.44 | 3.95 | 4.10 | 93,120 | |
| 12/30/2024 | 4.75 | 4.99 | 4.09 | 4.28 | 146,274 | |
| 12/27/2024 | 5.00 | 5.19 | 4.57 | 4.71 | 107,927 | |
| 12/26/2024 | 5.06 | 5.39 | 4.70 | 5.04 | 127,480 | |
| 12/24/2024 | 5.10 | 5.30 | 4.68 | 5.02 | 65,800 | |
| 12/23/2024 | 5.19 | 5.41 | 4.79 | 4.95 | 89,536 | |
| 12/20/2024 | 4.72 | 5.18 | 4.72 | 5.15 | 77,361 | |
| 12/19/2024 | 5.60 | 5.60 | 4.71 | 4.71 | 166,119 | |
| 12/18/2024 | 5.88 | 5.96 | 5.35 | 5.52 | 225,600 | |
| 12/17/2024 | 6.02 | 6.07 | 5.60 | 5.80 | 196,543 | |
| 12/16/2024 | 6.15 | 6.22 | 5.84 | 6.00 | 313,174 | |
| 12/13/2024 | 6.00 | 6.19 | 5.73 | 5.78 | 249,700 | |
| 12/12/2024 | 5.49 | 6.21 | 5.21 | 5.73 | 703,974 | |
| 12/11/2024 | 4.23 | 5.25 | 4.23 | 5.12 | 438,100 | |
| 12/10/2024 | 4.50 | 4.56 | 4.23 | 4.23 | 55,563 | |
| 12/09/2024 | 4.67 | 4.73 | 4.40 | 4.42 | 64,384 | |
| 12/06/2024 | 4.44 | 4.71 | 4.44 | 4.55 | 51,484 | |
| 12/05/2024 | 4.50 | 4.77 | 4.42 | 4.42 | 25,257 | |
| 12/04/2024 | 4.75 | 4.83 | 4.48 | 4.49 | 124,285 | |
| 12/03/2024 | 4.44 | 4.93 | 4.30 | 4.70 | 228,234 | |
| 12/02/2024 | 4.49 | 4.49 | 3.89 | 4.19 | 86,347 | |
| 11/29/2024 | 3.88 | 4.00 | 3.72 | 3.97 | 22,430 | |
| 11/27/2024 | 3.94 | 3.97 | 3.80 | 3.84 | 23,722 | |
| 11/26/2024 | 4.07 | 4.26 | 3.90 | 3.94 | 47,109 | |
| 11/25/2024 | 4.21 | 4.37 | 4.02 | 4.05 | 54,639 | |
| 11/22/2024 | 3.95 | 4.41 | 3.91 | 4.10 | 119,142 | |
| 11/21/2024 | 4.72 | 4.83 | 3.85 | 3.92 | 153,304 | |
| 11/20/2024 | 3.79 | 4.23 | 3.30 | 4.20 | 770,433 | |
| 11/19/2024 | 3.00 | 3.55 | 2.94 | 3.53 | 94,077 | |
| 11/18/2024 | 3.05 | 3.08 | 2.78 | 3.00 | 45,404 | |
| 11/15/2024 | 2.92 | 3.08 | 2.77 | 2.98 | 43,220 | |
| 11/14/2024 | 2.72 | 2.94 | 2.72 | 2.90 | 33,892 | |
| 11/13/2024 | 2.92 | 2.97 | 2.70 | 2.75 | 28,809 | |
| 11/12/2024 | 2.86 | 2.90 | 2.62 | 2.79 | 45,442 | |
| 11/11/2024 | 2.87 | 3.10 | 2.85 | 2.97 | 46,900 | |
| 11/08/2024 | 2.63 | 2.90 | 2.63 | 2.85 | 20,859 | |
| 11/07/2024 | 2.50 | 2.69 | 2.44 | 2.60 | 25,529 | |
| 11/06/2024 | 2.38 | 2.52 | 2.38 | 2.52 | 5,600 | |
| 11/05/2024 | 2.47 | 2.49 | 2.45 | 2.46 | 8,300 | |
| 11/04/2024 | 2.58 | 2.62 | 2.41 | 2.47 | 9,436 | |
| 11/01/2024 | 2.39 | 2.57 | 2.38 | 2.57 | 49,135 | |
| 10/31/2024 | 2.52 | 2.59 | 2.41 | 2.43 | 20,684 | |
| 10/30/2024 | 2.59 | 2.59 | 2.48 | 2.51 | 13,797 | |
| 10/29/2024 | 2.63 | 2.63 | 2.57 | 2.59 | 16,569 | |
| 10/28/2024 | 2.70 | 2.87 | 2.61 | 2.61 | 14,641 | |
| 10/25/2024 | 2.74 | 2.81 | 2.65 | 2.69 | 10,371 | |
| 10/24/2024 | 2.74 | 2.84 | 2.71 | 2.84 | 6,124 | |
| 10/23/2024 | 2.83 | 2.88 | 2.71 | 2.74 | 8,000 | |
| 10/22/2024 | 2.81 | 2.84 | 2.78 | 2.83 | 3,889 |
About Exagen Stock history
Exagen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Exagen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Exagen Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Exagen stock prices may prove useful in developing a viable investing in Exagen
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 20.3 M | 21.3 M | |
| Net Loss | -42.6 M | -40.5 M |
Exagen Quarterly Net Working Capital |
|
Exagen Stock Technical Analysis
Exagen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Exagen Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Exagen's price direction in advance. Along with the technical and fundamental analysis of Exagen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Exagen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1022 | |||
| Jensen Alpha | 0.8739 | |||
| Total Risk Alpha | 0.7076 | |||
| Sortino Ratio | 0.1382 | |||
| Treynor Ratio | 0.6852 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Exagen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exagen. If investors know Exagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exagen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.23) | Revenue Per Share | Quarterly Revenue Growth 0.066 | Return On Assets | Return On Equity |
The market value of Exagen Inc is measured differently than its book value, which is the value of Exagen that is recorded on the company's balance sheet. Investors also form their own opinion of Exagen's value that differs from its market value or its book value, called intrinsic value, which is Exagen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exagen's market value can be influenced by many factors that don't directly affect Exagen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exagen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Exagen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exagen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.